Equity to Asset ratio is calculated as total stockholders equity divided by total asset. The Medicines Co's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $-26.00 Mil. The Medicines Co's Total Assets for the quarter that ended in Sep. 2019 was $897.27 Mil.
The historical rank and industry rank for The Medicines Co's Equity-to-Asset or its related term are showing as below:
MDCO's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.59 * Ranked among companies with meaningful Equity-to-Asset only.
The Medicines Co Equity-to-Asset Historical Data
The historical data trend for The Medicines Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Medicines Co's Equity-to-Asset
For the Drug Manufacturers - Specialty & Generic subindustry, The Medicines Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Medicines Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, The Medicines Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where The Medicines Co's Equity-to-Asset falls into.
The Medicines Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
The Medicines Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Medicines Co (NAS:MDCO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
The Medicines Co Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of The Medicines Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
The Medicines Co (The Medicines Co) Business Description
The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDCO has been successfully added to your 